[1]
|
Yeh, E.T. (2011) Onco-Cardiology: The Time Has Come. Texas Heart Institute Journal, 38, 246 -247.
|
[2]
|
Siegel, R., DeSantis, C., Virgo, K., et al. (2012) Cancer Treatment and Survivorship Statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 220-241. https://doi.org/10.3322/caac.21149
|
[3]
|
Zamorano, J.L., Lancellotti, P., Rodriguez, M.D., et al. (2016) 2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed under the Auspices of the ESC Committee for Practice Guidelines: The Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC). European Journal of Heart Failure, 37, 2768-2801.
|
[4]
|
Khouri, M.G., Douglas, P.S., Mackey, J., et al. (2012) Cancer Therapy-Induced Cardiac Toxicity in Early Breast Cancer: Addressing the Unresolved Issues. Circulation, 126, 2749-2763.
https://doi.org/10.1161/CIRCULATIONAHA.112.100560
|
[5]
|
Cardinale, D., Sandri, M.T., Colombo, A., et al. (2004) Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chem-otherapy. Circulation, 109, 2749-2754.
https://doi.org/10.1161/01.CIR.0000130926.51766.CC
|
[6]
|
Hahn, V., Lenihan, D.J., Ky, B., et al. (2014) Cancer Therapy-Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies. Journal of the American Heart Association, 3, E000665.
https://doi.org/10.1161/JAHA.113.000665
|
[7]
|
黄恬. 心肌肌钙蛋白I在胸部肿瘤患者放疗时心肌损伤监测中的应用价值[J]. 河北医学, 2017, 23(6): 911-914.
|
[8]
|
Copur, M.S. and Obermiller, A. (2011) An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition. Clinical Col-orectal Cancer, 10, 151-156.
https://doi.org/10.1016/j.clcc.2011.03.021
|
[9]
|
Wacker, A., Lersch, C., Scherpinski, U., et al. (2003) High In-cidence of Angina Pectoris in Patients Treated with 5-Fluorouracil. A Planned Surveillance Study with 102 Patients. Oncology, 65, 108-112.
https://doi.org/10.1159/000072334
|
[10]
|
Grunwald, M.R., Howie, L., Diaz Jr., L.A., et al. (2012) Takotsubo Car-diomyopathy and Fluorouracil: Case Report and Review of the Literature. Journal of Clinical Oncology, 30, e11-e14. https://doi.org/10.1200/JCO.2011.38.5278
|
[11]
|
Akpek, G. and Hartshorn, K.L. (1999) Failure of Oral Nitrate and Calcium Channel Blocker Therapy to Prevent 5-Fluorouracil--Related Myocardial Ischemia: A Case Report. Cancer Chemotherapy and Pharmacology, 43, 157-161.
https://doi.org/10.1007/s002800050877
|
[12]
|
Ferrara, N., Hillan, K.J. and Novotny, W. (2005) Bevacizumab (Avastin), a Humanized Anti-VEGF Mono-Clonal Antibody for Cancer Therapy. Biochemical and Biophysical Research Communications, 333, 328-235.
https://doi.org/10.1016/j.bbrc.2005.05.132
|
[13]
|
Pande, A., Lombardo, J. and Spangenthal, E. (2007) Hypertension Secondary to Anti-Angiogenic Therapy: Experience with Bevacizumab. Anticancer Research, 27, 3465-3470.
|
[14]
|
Dincer, M. and Altundag, K. (2006) Angiotension-Converting Enzyme Inhibitors for Bevacizumab-Induced Hypertension. Annals of Pharmacotherapy, 40, 2278-2279. https://doi.org/10.1345/aph.1H244
|
[15]
|
Ksamba, T. and McDonald, D.M. (2007) Mechanisms of Adverse Effects of Anti-VEGF Therapy for Cancer. British Journal of Cancer, 96, 1788-1795. https://doi.org/10.1038/sj.bjc.6603813
|
[16]
|
Aparicio-Gallego, G., Afonso-Afonso, F.J., Leon-Mateos, L., et al. (2011) Molecular Basis of Hypertension Side Effects Induced by Sunitinib. Anticancer Drugs, 22, 1-8. https://doi.org/10.1097/CAD.0b013e3283403806
|
[17]
|
Porter, G.A., Bennett, W.M. and Sheps, S.C. (1990) Cy-closporine-Associated Hypertension. National High Blood Pressure Education Program. Archives of Internal Medicine, 150, 280-283.
https://doi.org/10.1001/archinte.1990.00390140036008
|
[18]
|
Skoro-Sajer, N., Marta, G., Gerges, C., et al. (2014) Surgical Specimens, Haemodynamics and Long-Term Outcomes after Pulmonary Endarterectomy. Thorax, 69, 116-122. https://doi.org/10.1136/thoraxjnl-2013-203746
|
[19]
|
Yeh, E.T. and Bickford, C.L. (2009) Cardiovascular Compli-cations of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management. Journal of the American College of Cardiology, 53, 2231-2247.
https://doi.org/10.1016/j.jacc.2009.02.050
|
[20]
|
Coughlin, S., Das, S., Lee, J., et al. (2008) Capecitabine Induced Vasospastic Angina. International Journal of Cardiology, 130, 34-36. https://doi.org/10.1016/j.ijcard.2007.06.152
|
[21]
|
Nieto, Y., Cagnoni, P., Bearman, S.I., et al. (2000) Cardiac Tox-icity Following High Dose Cyclophoph Amide, Cisplatin and BCNU for Breast Cancer. Biology of Blood and Marrow Transplantation, 6, 198-203.
https://doi.org/10.1016/S1083-8791(00)70043-7
|
[22]
|
Priori, S.G., Blomström-Lundqvist, C., Mazzanti, A., et al. (2015) 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal, 36, 2793-2867.
|
[23]
|
Skoro-Sajer, N., Hack, N., Sadushi-Koliçi, R., et al. (2009) Pulmonary Vascular Reactivity and Prognosis in Patients with Chronic Thromboembolic Pulmonary Hypertension A Pilot Study. Circulation, 119, 298-305.
https://doi.org/10.1161/CIRCULATIONAHA.108.794610
|
[24]
|
Bonderman, D., Skoro-Sajer, N., Jakowitsch, J., et al. (2007) Predictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension. Circulation, 115, 2153-2158. https://doi.org/10.1161/CIRCULATIONAHA.106.661041
|
[25]
|
Jamieson, S.W., Kapelanski, D.P., et al. (2003) Pulmonary Endarterectomy: Experience and Lessons Learned in 1,500 Cases. The Annals of Thoracic Surgery, 76, 1457-1462. https://doi.org/10.1016/S0003-4975(03)00828-2
|
[26]
|
Dartevelle, P., Fadel, E., Mussot, S., et al. (2004) Chronic Thromboembolic Pulmonary Hypertension. European Respiratory Society, 23, 637-648. https://doi.org/10.1183/09031936.04.00079704
|
[27]
|
Ranpura, V., Hapani, S., Chuang, J. and Wu, S. (2010) Risk of Cardiac Ischemia and Arterial Thromboembolic Events with the Angiogenesis Inhibitor Bevacizuab in Cancer Patients: A Meta-Analysis of Randomized Controlled Trials. Acta Oncologica, 49, 287-297. https://doi.org/10.3109/02841860903524396
|
[28]
|
Zangari, M., Fink, L.M., Elice, F., Zhan, F. and Adcock, D.M. (2009) Thrombotic Events in Patients with Cancer Receiving Antiangiogenesis Agents. Journal of Clinical Oncology, 27, 4865-4873.
https://doi.org/10.1200/JCO.2009.22.3875
|
[29]
|
Bair, S.M., Choueiri, T.K. and Moslehi, J. (2013) Cardiovascular Complications Associated with Novel Angiogenesis Inhibitors: Emerging Evidence and Evolving Perspective. Trends in Cardiovascular Medicine, 23, 104-113.
https://doi.org/10.1016/j.tcm.2012.09.008
|
[30]
|
Kunihara, T., Gerdts, J., Groesdonk, H., et al. (2011) Predictors of Postoperative Outcome after Pulmonary Endarterectomy from a 14-Year Experience with 279 Patients. European Journal of Cardio-Thoracic Surgery, 40, 154-161.
https://doi.org/10.1016/j.ejcts.2010.10.043
|
[31]
|
Jaworski, C., Mariani, J.A., Wheeler, G., et al. (2013) Cardiac Complications of Thoracic Irradiation. Journal of the American College of Cardiology, 61, 2319-2328. https://doi.org/10.1016/j.jacc.2013.01.090
|
[32]
|
Hull, M.C., Morris, C.G., Pepine, C.J. and Mendenhall, N.P. (2003) Valvular Dysfunction and Carotid, Subclavian and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated with Radiation Therapy. Journal of the American Medical Association, 290, 2831-2837. https://doi.org/10.1001/jama.290.21.2831
|
[33]
|
Hering, D., Faber, L. and Horstkotte, D. (2003) Echocardiographic Features of Radiation-Associated Valvular Disease. American Journal of Cardiology, 92, 226-230. https://doi.org/10.1016/S0002-9149(03)00546-0
|
[34]
|
Vahanian, A., Alfieri, O., Andreotti, F., et al. (2012) Guidelines on the Management of Valvular Heart Disease (Version 2012). European Heart Journal, 33, 2451-2496. https://doi.org/10.1093/eurheartj/ehs109
|
[35]
|
Ogino, H., Ando, M., Matsuda, H., et al. (2006) Japanese Sin-gle-Center Experience of Surgery for Chronic Thrombo-Embolic Pulmonary Hypertension. The Annals of Thoracic Surgery, 82, 630-636.
https://doi.org/10.1016/j.athoracsur.2006.03.121
|
[36]
|
Mortimer, J.E., Crowley, J., Eyre, H. and Weiden, P. (1992) A Phase II Randomized Study Comparing Sequential and Combined Intraarterial Cisplatin and Radiation Therapy in Primary Brain Tumors. A Southwest Oncology Group Study. Cancer, 69, 1220-1223. https://doi.org/10.1002/cncr.2820690525
|
[37]
|
Kramm, T., Eberle, B., Guth, S., et al. (2005) Inhaled Iloprost to Control Residual Pulmonary Hypertension Following Pulmonary Endarterectomy. European Journal of Cardio-Thoracic Surgery, 28, 882-888.
https://doi.org/10.1016/j.ejcts.2005.09.007
|
[38]
|
Ghofrani, H.A., D’Armini, A.M., Grimminger, F., et al. (2013) Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension. The New England Journal of Med-icine, 369, 319-329.
https://doi.org/10.1056/NEJMoa1209657
|
[39]
|
Seemann, I., Gillette, K. and Visser, N.L. (2012) Irradiation Induced Modest Changes in Murine Cardiac Function Despite Progressive Structural Damage to the Myocardium and Microvasculature. Radiotherapy and Oncology, 103, 143-150. https://doi.org/10.1016/j.radonc.2011.10.011
|
[40]
|
Stewart, J.R., Fajardo, L.F., Gillette, S.M., et al. (1995) Radia-tion Injury to the Heart. International Journal of Radiation Oncology, Biology, Physics, 31, 1205-1211. https://doi.org/10.1016/0360-3016(94)00656-6
|
[41]
|
彭毅, 谭文勇. 抗肿瘤治疗相关的心脏血管毒性: 肿瘤心脏病学亟待跟进[J]. 临床与病理杂志, 2015, 35(3): 433-443.
|